Farshad Forouzandeh, MD, PhD
-
Specialty: Cardiology-Interventional Cardiology
View Expertise -
Primary Location: 5901 E Royalton Rd (13 mi.)
Other Locations - Languages Spoken: English, French, Farsi
Office Locations
UH Broadview Hts Health Center (13 mi.)
5901 E Royalton Rd
Ste 2400
Broadview Heights, OH 44147
440-882-0075
UH Parma Medical Arts Building 3 (11 mi.)
6525 Powers Blvd
Medical Arts Cntr 3 Ste 301
Parma, OH 44129
440-882-0075
Biography: Farshad Forouzandeh, MD, PhD
Expertise
Titles
- Associate Professor, CWRU School of Medicine
Certifications & Memberships
- Interventional Cardiology - American Board of Internal Medicine
- Cardiovascular Disease - American Board of Internal Medicine
Education
Fellowship | Interventional Cardiology
Interventional Cardiology - Emory University Hospital (2016 - 2017)
Fellowship | Cardiovascular Disease
Cardiovascular Disease - Emory University Hospital (2012 - 2016)
Residency | Internal Medicine
Internal Medicine - Methodist Hospital (Houston) (2009 - 2012)
Other Education
University Of British Columbia (2009)
Medical Education
Tehran University Of Medical Sciences (2005)
About
Farshad Forouzandeh, MD, PhD, FACC, FSCAI, is an interventional cardiologist in University Hospitals Harrington Heart & Vascular Institute. He is also an Associate Professor at Case Western Reserve University School of Medicine (CWRU).
Dr Forouzandeh earned his medical degree from Tehran University of Medical Sciences at the top of his class and his doctorate in philosophy (PhD) in experimental medicine from the University of British Columbia. Dr. Forouzandeh then completed an internal medicine residency at The Methodist Hospital, Weill Cornell Medical College in Houston, Texas and two fellowships, in cardiology and interventional cardiology, at Emory University in Atlanta, Georgia.
Dr. Forouzandeh has authored more than 90 peer-reviewed articles, abstracts and presentations on both translational and clinical aspects of cardiovascular disease. He is a review editor for Frontiers in Cardiovascular Medicine, and associate editor for U.S. Cardiology Reviews and European Heart Journal Case Reports. He is a member of the Society for Cardiovascular Angiography and Interventions (SCAI), American Heart Association (AHA), American College of Physicians (ACP) and American College of Cardiology (ACC) where he has served on the National Cardiovascular Data Registry (NCDR) Research and Publications Committee.
Dr. Forouzandeh has received numerous prestigious recognitions including American Heart Association Post-Doctoral Fellowship, British Columbia Innovation Council Award, Best Resident of the Year, and top presentation and research competition awards at local, national and international levels. He also contributes regularly as an invited faculty in several national and international cardiovascular scientific meetings such as ACC, SCAI, Cardiovascular Innovations (CVI), Cardiovascular Research Technologies (CRT) and many more.
Connect with Dr. Forouzandeh
Featured Videos
Watch to find out more about this University Hospitals provider.
Patient Experience Reviews
Very good experience with the care provider.
Very happy with the Doctor and the staff. Did recommend the Doctor to friends and family members. Impressed with the thoroughness of the examination and the Doctors concerns about my health. Thank You.
I feel comfortable about the knowledge & skill of the doctor.
All my interactions with the doctor and staff were very positive.
Excellent
No complaints. I was very satisfied with the service that was rendered.
Dr. And staff were very helpful and attentive.
Excellent provider
This was the first time I had an appointment with this provider
Great Dr.!
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Farshad Forouzandeh did not disclose any Outside Relationships with Industry.